| scholarly article | Q13442814 |
| P50 | author | Lars Ragnar Furenlid | Q102426666 |
| P2093 | author name string | Li Wan | |
| Hua Xu | |||
| James M Woolfenden | |||
| Zhonglin Liu | |||
| Leonie Wyffels | |||
| Christy Barber | |||
| Mizhou M Hui | |||
| P2860 | cites work | Novel targets for interleukin 18 binding protein | Q24292449 |
| Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions | Q28281475 | ||
| A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF | Q28296638 | ||
| Biologic basis for interleukin-1 in disease | Q29619853 | ||
| Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. | Q33237318 | ||
| Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis | Q33544594 | ||
| Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist | Q33836551 | ||
| Soluble cytokine receptors: novel immunotherapeutic agents | Q34074749 | ||
| The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist | Q34299287 | ||
| Inflammatory cytokines and postmyocardial infarction remodeling | Q34329136 | ||
| Soluble cytokine receptors in biological therapy | Q34779777 | ||
| Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment | Q35165663 | ||
| A (99m)Tc-labeled dual-domain cytokine ligand for imaging of inflammation | Q35167359 | ||
| Inflammatory mechanisms in myocardial infarction. | Q35560507 | ||
| Seeing within: molecular imaging of the cardiovascular system | Q35682892 | ||
| Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts | Q35764715 | ||
| Targeted ultrasound imaging using microbubbles | Q35781749 | ||
| Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease | Q35882174 | ||
| Etanercept (Enbrel) -- an update | Q36013256 | ||
| Role of biological agents in immune-mediated inflammatory diseases | Q36067282 | ||
| The pathophysiology of tumor necrosis factors | Q36135208 | ||
| Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process | Q36392611 | ||
| Application of radioisotopes in inflammation. | Q36447212 | ||
| Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway | Q36448851 | ||
| Soluble and cell surface receptors for tumor necrosis factor. | Q36461578 | ||
| Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo | Q37031936 | ||
| Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques | Q37809648 | ||
| The role of radiolabelled anti-TNFa monoclonal antibodies for diagnostic purposes and therapy evaluation | Q37827331 | ||
| Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium | Q38138494 | ||
| Anticytokine therapy for osteoarthritis: evidence to date | Q39906208 | ||
| Topical transduction of superoxide dismutase mediated by HIV-1 Tat protein transduction domain ameliorates 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice | Q40029455 | ||
| Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies. | Q40666593 | ||
| Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation | Q41031027 | ||
| Protective effects of black rice bran against chemically-induced inflammation of mouse skin | Q42929289 | ||
| 3,3'-diindolylmethane suppresses 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators | Q43011666 | ||
| Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate. | Q43861402 | ||
| Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection | Q44061315 | ||
| Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans | Q44303687 | ||
| Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function | Q44319404 | ||
| TNF-alpha enhances cardiac myocyte NO production through MAP kinase-mediated NF-kappaB activation | Q44864752 | ||
| Topical antiinflammatory effects of the ether extract from Protium kleinii and alpha-amyrin pentacyclic triterpene | Q45230410 | ||
| Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats | Q46186351 | ||
| Regulatory T cells control VEGF-dependent skin inflammation | Q46226178 | ||
| TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis | Q46519096 | ||
| Involvement of tumor necrosis factor (TNF)-alpha in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice | Q46951358 | ||
| Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. | Q53421778 | ||
| PET imaging of acute and chronic inflammation in living mice. | Q53478799 | ||
| Induction of interleukin-1 and tumor necrosis factor by 12-O-tetradecanoylphorbol-13-acetate in phorbol ester-sensitive (SENCAR) and resistant (B6C3F1) mice. | Q53514863 | ||
| Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. | Q53713467 | ||
| Radiolabelled interleukin‐1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis | Q57779744 | ||
| Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties | Q70524893 | ||
| Labelling small quantities of monoclonal antibodies and their F(ab')2 fragments with technetium-99m | Q71720460 | ||
| Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis | Q73363905 | ||
| Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies? | Q73537269 | ||
| Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction | Q73580789 | ||
| Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis | Q77403524 | ||
| 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction | Q80044889 | ||
| Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in mice | Q84057850 | ||
| Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis | Q94174926 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 905-915 | |
| P577 | publication date | 2012-06-28 | |
| P1433 | published in | Nuclear Medicine and Biology | Q7067979 |
| P1476 | title | Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways | |
| P478 | volume | 39 |
| Q55052878 | Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines. |
| Q57152800 | Antibody-based tracers for PET/SPECT imaging of chronic inflammatory diseases |
| Q34315928 | Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand |
| Q42408511 | Molecular Imaging in the College of Optical Sciences - An Overview of Two Decades of Instrumentation Development |
| Q37321664 | SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand |
| Q38217595 | Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects |
Search more.